ScholarIQanswers from OpenAlex

The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis

PaperCitations, authors & open-access status

The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis have?

ScholarIQcitation count

The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis has 1 citations in the OpenAlex counts ScholarIQ stores.

When was The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis published?

ScholarIQyear

The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis has 2026 year in the ScholarIQ index.

What is the open-access status of The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis?

ScholarIQoa status

The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis has gold oa status in the ScholarIQ index.

What is the DOI of The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis?

ScholarIQdoi

The DOI for The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis is on the source record.

What is the PMID of The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis?

ScholarIQpmid

The PMID for The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis is on the source record.

What is the OpenAlex record for The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis?

ScholarIQopenalex

The OpenAlex for The primary preventive effect of sodium–glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial